GW Pharmaceuticals PLC Company Profile (NASDAQ:GWPH)

About GW Pharmaceuticals PLC

GW Pharmaceuticals PLC logoGW Pharmaceuticals plc is a biopharmaceutical company focused on developing and commercializing therapeutics from its cannabinoid product platform in a range of disease areas. The Company's lead cannabinoid product candidate is Epidiolex, which is a liquid formulation of pure plant-derived cannabidiol (CBD). The Company offers Sativex (nabiximols), which is indicated for the treatment of spasticity due to multiple sclerosis (MS). The Company operates through three segments: Commercial, Sativex Research and Development, and Pipeline Research and Development. The Commercial segment distributes and sells the Company's commercial products. The Sativex Research and Development segment seeks to maximize the potential of Sativex through the development of new indications. The Pipeline Research and Development segment seeks to develop cannabinoid medications other than Sativex across a range of therapeutic areas using its cannabinoid technology platform.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Manufacturers - Major
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: GWPH
  • CUSIP:
Key Metrics:
  • Previous Close: $129.59
  • 50 Day Moving Average: $120.98
  • 200 Day Moving Average: $113.22
  • 52-Week Range: $35.83 - $137.88
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -31.45
  • P/E Growth: 0.45
  • Market Cap: $3.27B
  • Outstanding Shares: 25,225,000
  • Beta: 2.72
Profitability:
  • Net Margins: -702.90%
  • Return on Equity: -20.07%
  • Return on Assets: -17.00%
Debt:
  • Debt-to-Equity Ratio: 0.01%
  • Current Ratio: 9.92%
  • Quick Ratio: 9.81%
Additional Links:
Companies Related to GW Pharmaceuticals PLC:

Analyst Ratings

Consensus Ratings for GW Pharmaceuticals PLC (NASDAQ:GWPH) (?)
Ratings Breakdown: 1 Sell Rating, 1 Hold Rating, 8 Buy Ratings
Consensus Rating:Buy (Score: 2.70)
Consensus Price Target: $150.44 (16.09% upside)

Analysts' Ratings History for GW Pharmaceuticals PLC (NASDAQ:GWPH)
Show:
DateFirmActionRatingPrice TargetDetails
2/6/2017Cowen and CompanySet Price TargetBuy$135.00View Rating Details
2/7/2017Piper Jaffray CompaniesSet Price TargetBuy$147.00View Rating Details
2/7/2017Cantor FitzgeraldSet Price TargetBuy$208.00View Rating Details
1/13/2017Goldman Sachs Group, Inc. (The)Initiated CoverageBuy$189.00View Rating Details
11/3/2016Leerink SwannReiterated RatingBuy$162.00View Rating Details
9/25/2016Morgan StanleyBoost Price TargetOverweight$152.00 -> $160.00View Rating Details
8/26/2016Numis Securities LtdUpgradeSell -> HoldView Rating Details
7/18/2016Bank of America CorpReiterated RatingBuy$153.00View Rating Details
6/27/2016Janney Montgomery ScottInitiated CoverageSell$40.00View Rating Details
3/14/2016Roth CapitalBoost Price TargetBuy$130.00 -> $160.00View Rating Details
(Data available from 2/20/2015 forward)

Earnings

Earnings History for GW Pharmaceuticals PLC (NASDAQ:GWPH)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/7/2017Q117($1.69)($0.77)$1.85 million$2.54 millionViewListenView Earnings Details
12/6/2016Q416($1.58)($0.89)$2.16 millionViewListenView Earnings Details
5/5/2016Q216($1.57)($0.09)$5.99 million$3.81 millionViewN/AView Earnings Details
2/10/2016Q116($1.53)($0.10)$4.61 million$5.40 millionViewListenView Earnings Details
12/7/2015Q415($1.37)($0.85)$15.00 million$5.60 millionViewN/AView Earnings Details
8/6/2015Q315($1.30)($1.60)$12.82 million$13.55 millionViewN/AView Earnings Details
5/11/2015Q215($1.23)($0.58)$11.38 million$9.43 millionViewListenView Earnings Details
2/4/2015Q115($1.25)($0.02)$12.12 million$12.40 millionViewN/AView Earnings Details
12/2/2014Q414($0.69)$0.02$9.15 million$12.03 millionViewN/AView Earnings Details
8/6/2014Q314($1.08)$0.06$12.88 million$13.00 millionViewN/AView Earnings Details
5/7/2014Q114($0.48)($0.04)$12.48 million$12.55 millionViewN/AView Earnings Details
2/4/2014Q413($0.34)($0.02)$11.54 million$7.49 millionViewN/AView Earnings Details
11/19/2013Q4($0.19)($0.29)ViewListenView Earnings Details
8/5/2013Q313($0.11)$0.02$10.71 million$11.04 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for GW Pharmaceuticals PLC (NASDAQ:GWPH)
Current Year EPS Consensus Estimate: $-5.74 EPS
Next Year EPS Consensus Estimate: $-4.12 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20163($2.35)($1.98)($2.13)
Q2 20163($2.40)($1.44)($2.00)
Q3 20163($2.23)($1.44)($1.89)
Q4 20161($1.62)($1.62)($1.62)
Q1 20171($1.80)($1.80)($1.80)
Q2 20171($1.98)($1.98)($1.98)
Q3 20171($2.34)($2.34)($2.34)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for GW Pharmaceuticals PLC (NASDAQ:GWPH)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for GW Pharmaceuticals PLC (NASDAQ:GWPH)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for GW Pharmaceuticals PLC (NASDAQ:GWPH)
DateHeadline
News IconWhy GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) Is Getting Market Attention? (NASDAQ:GWPH)
mmjreporter.com - February 14 at 11:53 PM
capitalcube.com logoETFs with exposure to GW Pharmaceuticals Plc : February 14, 2017 (NASDAQ:GWPH)
www.capitalcube.com - February 14 at 6:52 PM
fool.com logoTop 5 States for Marijuana Stocks (NASDAQ:GWPH)
www.fool.com - February 14 at 6:52 PM
4-traders.com logoGW Pharmaceuticals : UK has future as medicinal cannabis hub (NASDAQ:GWPH)
www.4-traders.com - February 13 at 6:32 PM
News IconGW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) Remains A Top Cannabis Pick (NASDAQ:GWPH)
www.insiderfinancial.com - February 13 at 6:32 PM
News IconShares of GW Pharmaceuticals Plc (GWPH) Sees Large Inflow of Net Money Flow - Highland Mirror (NASDAQ:GWPH)
www.highlandmirror.com - February 13 at 11:37 AM
fool.com logo2 Billion-Dollar Marijuana Stocks That Could Soar Even Higher (NASDAQ:GWPH)
www.fool.com - February 13 at 11:37 AM
fool.com logoThis Technology Could Be a Game-Changer for the Marijuana Industry (NASDAQ:GWPH)
www.fool.com - February 11 at 5:39 PM
capitalcube.com logoGW Pharmaceuticals Plc :GWPH-US: Earnings Analysis: Q1, 2017 By the Numbers : February 9, 2017 (NASDAQ:GWPH)
us.rd.yahoo.com - February 9 at 11:31 PM
benzinga.com logoAnalyst: GW Pharma's GBM Was Validated - Benzinga (NASDAQ:GWPH)
www.benzinga.com - February 9 at 6:29 PM
seekingalpha.com logoGW Pharma Results Set Up Exciting 2017 - Seeking Alpha (NASDAQ:GWPH)
seekingalpha.com - February 9 at 6:29 PM
nasdaq.com logoGW Pharma (GWPH) Posts Narrower-than-Expected Loss in Q1 - Nasdaq (NASDAQ:GWPH)
www.nasdaq.com - February 9 at 6:29 PM
us.rd.yahoo.com logoBiotech Stock Roundup: Amgen, Gilead Report 4Q Results, ARIAD Seeks EU Nod for Brigatinib (NASDAQ:GWPH)
us.rd.yahoo.com - February 8 at 6:12 PM
finance.yahoo.com logoGW Pharmaceuticals to Present at the Leerink Partners 6th Annual Global Healthcare Conference on 15 February (NASDAQ:GWPH)
finance.yahoo.com - February 8 at 6:12 PM
News IconGW Pharmaceuticals Q1 Profit & Revenue Beat The Street (NASDAQ:GWPH)
prensariotiretail.com - February 7 at 11:52 PM
News IconGW Pharma’s Cannabis-Derived Drug Shows Promise in Brain Cancer Study (NASDAQ:GWPH)
www.bioportfolio.com - February 7 at 6:51 PM
investopedia.com logoGW Pharma Spikes on Cannabis Drug Success (GWPH) (NASDAQ:GWPH)
www.investopedia.com - February 7 at 6:51 PM
nasdaq.com logoEarnings Reaction History: GW Pharmaceuticals plc, 20.0% Follow-Through Indicator, 3.1% Sensitive (NASDAQ:GWPH)
www.nasdaq.com - February 7 at 6:51 PM
News IconGW Pharma Reports FY17-Q1 Financials (NASDAQ:GWPH)
www.newcannabisventures.com - February 7 at 6:51 PM
smarteranalyst.com logoCompany Update (NASDAQ:GWPH): GW Pharmaceuticals PLC- ADR Achieves Positive Results in Phase 2 Proof of Concept Study in Glioma (NASDAQ:GWPH)
www.smarteranalyst.com - February 7 at 6:51 PM
News IconGW Pharmaceuticals PLC (GWPH) Issues Quarterly Earnings Results (NASDAQ:GWPH)
mundoaguaysaneamiento.net - February 7 at 6:51 PM
finance.yahoo.com logoGW Pharmaceuticals Achieves Positive Results in Phase 2 Proof of Concept Study in Glioma (NASDAQ:GWPH)
finance.yahoo.com - February 7 at 6:51 PM
finance.yahoo.com logoGW Pharmaceuticals plc Reports First Quarter 2017 Financial Results and Operational Progress (NASDAQ:GWPH)
finance.yahoo.com - February 7 at 6:51 PM
finance.yahoo.com logo7:02 am GW Pharma announces 'positive' top-line results from an exploratory Phase 2 placebo-controlled clinical study of a proprietary combination of THC and CBD in 21 patients with recurrent glioblastoma multiforme (NASDAQ:GWPH)
finance.yahoo.com - February 7 at 6:51 PM
finance.yahoo.com logoWhy Cannabinoid Developer GW Pharma Looks Better Than Ever to Investors (NASDAQ:GWPH)
finance.yahoo.com - February 7 at 6:51 PM
finance.yahoo.com logoGW Pharma Posts Narrower-than-Expected Loss in Q1; Sales Beat (NASDAQ:GWPH)
finance.yahoo.com - February 7 at 6:51 PM
finance.yahoo.com logoGW Pharma Takes A Step Toward Diversifying (NASDAQ:GWPH)
finance.yahoo.com - February 7 at 6:51 PM
investopedia.com logoGW Pharmaceuticals Cannabis Drug Aids Brain Cancer (NASDAQ:GWPH)
www.investopedia.com - February 7 at 6:51 PM
feeds.benzinga.com logoAnalyst: GW Pharma's GBM Was Validated (NASDAQ:GWPH)
feeds.benzinga.com - February 7 at 11:33 AM
fool.com logoIs This Hot Marijuana Stock Too Expensive to Buy? (NASDAQ:GWPH)
us.rd.yahoo.com - February 6 at 5:39 PM
finance.yahoo.com logoInvestor Network Invites You to the GW Pharmaceuticals First Quarter 2017 Earnings Conference Call and Webcast Live on Tuesday, February 7, 2017 (NASDAQ:GWPH)
finance.yahoo.com - February 6 at 5:39 PM
fool.com logoBetter Marijuana Stock to Buy: GW Pharmaceuticals or Insys Therapeutics? (NASDAQ:GWPH)
www.fool.com - February 4 at 5:37 PM
News IconGW Pharmaceuticals Plc (GWPH) Valuation According To Analysts ... - UK Market News (NASDAQ:GWPH)
www.ukmarketnews.co.uk - February 3 at 11:07 PM
finance.yahoo.com logoGW Pharmaceuticals (GWPH) Q1 Earnings: What's in Store? - Yahoo Finance (NASDAQ:GWPH)
finance.yahoo.com - February 3 at 11:07 PM
us.rd.yahoo.com logoGW Pharmaceuticals (GWPH) Q1 Earnings: What's in Store? (NASDAQ:GWPH)
us.rd.yahoo.com - February 2 at 6:12 PM
realistinvestor.com logoGW Pharmaceuticals Plc (NASDAQ:GWPH) EPS Projection At $-0.19 - RealistInvestor.com (NASDAQ:GWPH)
www.realistinvestor.com - February 1 at 6:17 PM
News IconGW Pharmaceuticals Plc (NASDAQ:GWPH) Stock ABR At 1.64 - Stock Observer (NASDAQ:GWPH)
www.thestockobserver.com - February 1 at 6:17 PM
News IconAnalysts Are Circling GW Pharmaceuticals Plc (NASDAQ:GWPH): What is the Consensus' Take? - Wall Street Beacon (NASDAQ:GWPH)
wsbeacon.com - February 1 at 6:17 PM
News Icon$GWPH to Report Q1 Financial Results and Host Conference Call (NASDAQ:GWPH)
marijuanastocks.com - January 30 at 11:20 PM
nasdaq.com logoGW Pharmaceuticals to Report Q1 Financial Results and Host Conference Call on 7 February, 2017 - Nasdaq (NASDAQ:GWPH)
www.nasdaq.com - January 30 at 11:34 AM
News IconGoldman Sachs Has A Buy Rating On GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) - MMJ Observer (NASDAQ:GWPH)
www.mmjobserver.com - January 30 at 11:34 AM
News IconIs There Inherent Value in GW Pharmaceuticals Plc (NASDAQ:GWPH)? Analysts Delve Into The Stock - Wall Street Beacon (NASDAQ:GWPH)
wsbeacon.com - January 29 at 5:39 PM
thestreet.com logoYou Can Also Get High on Marijuana Stocks -- Here's How (NASDAQ:GWPH)
us.rd.yahoo.com - January 28 at 5:42 PM
us.rd.yahoo.com logoCannabis Drug Company Zynerba Is Gearing Up For A Big Summer (NASDAQ:GWPH)
us.rd.yahoo.com - January 27 at 12:08 AM
realistinvestor.com logoEPS Projection Of GW Pharmaceuticals Plc (NASDAQ:GWPH) At $-0.19 - RealistInvestor.com (NASDAQ:GWPH)
www.realistinvestor.com - January 26 at 4:58 AM
News IconSell-side Target Update on GW Pharmaceuticals Plc (NASDAQ:GWPH) Stock - Aiken Advocate (NASDAQ:GWPH)
aikenadvocate.com - January 26 at 4:58 AM
News IconSell-Side Ratings Review on Shares of GW Pharmaceuticals Plc (NASDAQ:GWPH) - Wall Street Beacon (NASDAQ:GWPH)
wsbeacon.com - January 26 at 4:58 AM
fool.com logo3 Reasons GW Pharmaceuticals Stock Could Rise (NASDAQ:GWPH)
www.fool.com - January 23 at 11:17 AM
fool.com logoHere's Everything You've Ever Wanted to Know About Marijuana (NASDAQ:GWPH)
us.rd.yahoo.com - January 22 at 5:28 PM
finance.yahoo.com logoCannabis Industry Expert Jay Czarkowski On The Challenges Of Marijuana Legalization And Business Compliance (NASDAQ:GWPH)
finance.yahoo.com - January 20 at 6:56 PM

Social

What is GW Pharmaceuticals PLC's stock symbol?

GW Pharmaceuticals PLC trades on the NASDAQ under the ticker symbol "GWPH."

Where is GW Pharmaceuticals PLC's stock going? Where will GW Pharmaceuticals PLC's stock price be in 2017?

10 equities research analysts have issued 1 year target prices for GW Pharmaceuticals PLC's shares. Their forecasts range from $40.00 to $208.00. On average, they expect GW Pharmaceuticals PLC's share price to reach $150.44 in the next twelve months.

Who owns GW Pharmaceuticals PLC stock?

GW Pharmaceuticals PLC's stock is owned by a number of of institutional and retail investors. Top institutional investors include Prudential PLC (8.15%), FMR LLC (6.81%), Deerfield Management Co. (3.68%), Viking Global Investors LP (3.61%), Janus Capital Management LLC (2.58%) and Franklin Resources Inc. (1.74%).

Who sold GW Pharmaceuticals PLC stock? Who is selling GW Pharmaceuticals PLC stock?

GW Pharmaceuticals PLC's stock was sold by a variety of institutional investors in the last quarter, including Janus Capital Management LLC, Deerfield Management Co., Viking Global Investors LP, Federated Investors Inc. PA, FMR LLC, Van ECK Associates Corp, Fiera Capital Corp and Nicholas Investment Partners LP.

Who bought GW Pharmaceuticals PLC stock? Who is buying GW Pharmaceuticals PLC stock?

GW Pharmaceuticals PLC's stock was acquired by a variety of institutional investors in the last quarter, including Prudential PLC, Orbimed Advisors LLC, Brown Capital Management LLC, Franklin Resources Inc., Allianz Asset Management AG, Clough Capital Partners L P, ING Groep NV and Commerzbank Aktiengesellschaft FI.

How do I buy GW Pharmaceuticals PLC stock?

Shares of GW Pharmaceuticals PLC can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of GW Pharmaceuticals PLC stock cost?

One share of GW Pharmaceuticals PLC stock can currently be purchased for approximately $129.59.

GW Pharmaceuticals PLC (NASDAQ:GWPH) Chart for Monday, February, 20, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for GW Pharmaceuticals PLC (NASDAQ:GWPH)

Earnings History Chart

Earnings by Quarter for GW Pharmaceuticals PLC (NASDAQ:GWPH)

Dividend History Chart

Dividend Payments by Quarter for GW Pharmaceuticals PLC (NASDAQ:GWPH)

Last Updated on 2/20/2017 by MarketBeat.com Staff